Advancing neurologic studies for movement disorders and comprehensive treatment approaches
Dr. Mark Lew, director of the Division of Movement Disorders at the Keck School of Medicine of USC is advancing research in new pharmacologic therapies for Parkinson's disease. For the last two decades, the Division of Movement Disorders in the department of Neurology at the Keck/USC School of Medicine has participated in clinical trials for all FDA approved medications to treat Parkinson's disease. This has allowed hundreds of Parkinson's disease (PD) patients to receive new treatments years before they were commercially available. These patients are provided lifelong care through the Center well after the end of their participation in clinical trials. This comprehensive treatment approach positively and effectively changes the patient's lives. Other clinical projects include development of novel potential biomarkers for Parkinson's disease.
- A vital component of the program's success is a comprehensive, multi-disciplinary approach to PD therapy. Every patient is evaluated to assess their individual need for therapy by speech, occupational, and physical therapists as well as clinical psychologists. Developing individualized disease-specific treatment programs for each patient is a unique approach to care that affords all patients regardless of financial capacity a successful outcome. As the World Health Organization estimates that the number of individuals with Parkinson's disease will double over the next 15 years, it is of tantamount importance that such programs are in place with a developed infrastructure to provide this high level of comprehensive care.
The Division of Movement Disorders at USC has devoted energy and resources to organize Continuing Medical Education (CME) programs for community physicians to better allow them to diagnose and treat Parkinson's disease in an up-to-date fashion. Residents, medical students and post-graduate fellows are all educated extensively on the evaluation and treatment of patients with various movement disorders. Similarly, there is a long standing history of educating patients and family members with yearly symposia.
Dr. Lew is a Professor of Neurology and the Director of the Division of Movement Disorders and serves as the Vice Chairman of the Department of Neurology at the Keck/USC School of Medicine. He is a board certified neurologist and a fellow of the American Academy of Neurology and American Neurologic Association
Dr. Lew has an international reputation for the treatment of patients with Parkinson's disease, dystonia, and other movement disorders. He has lectured extensively in the United States and abroad on clinical research related to new therapies for Parkinson's disease and dystonia.
He also collaborates closely with local and national advocacy organizations (e.g., the Hollyrod Foundation and the National Parkinson's Foundation, Michael J. Fox Foundation) to increase public awareness and to support research and care.
He is currently focusing on research in new pharmacologic treatments for Parkinson's disease. In addition, he is conducting clinical trials using new forms of botulinum toxin to treat focal dystonias. He is a Participating Scientist of both the Parkinson's Study Group and the Dystonia Study Group.
In the News
Castle Connolly America Top Doctors
Award Winner 2011 and 2012
HollyRod Foundation Founder
Award Winner July 2007